The Dexamethasone/Corticotropin-Releasing Factor Test in Men with Major Depression: Role of Childhood Trauma

Biological Psychiatry

Volumn 63, Issue 4, 2008, Pages 398-405

  Heim, Christine ^a   Mletzko, Tanja ^a   Purselle, David ^a   Musselman, Dominique L ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cortisol; dexamethasone; HPA axis hyperactivity; MDD; trauma

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE;

ADULT; ARTICLE; CHILD ABUSE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DEXAMETHASONE CORTICOTROPIN RELEASING FACTOR TEST; DISEASE SEVERITY; ENDOCRINE FUNCTION TEST; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTRAUMA; RISK FACTOR;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ADULT SURVIVORS OF CHILD ABUSE; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SEVERITY OF ILLNESS INDEX; SOCIAL ENVIRONMENT; STRESS DISORDERS, POST-TRAUMATIC;

EID: 38349131059     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.07.002     Document Type: Article

References (56)

1. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
2. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
3. Holsboer F., Von Bardeleben U., Gerken A., Stalla G.K., and Muller O.A. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 311 (1984) 1127
4. Gold P.W., Chrousos G., Kellner C., Post R., Roy A., Augerinos P., et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 141 (1984) 619-627
5. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226 (1984) 1342-1344
6. Hartline K.M., Owens M.J., and Nemeroff C.B. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans. Ann N Y Acad Sci 780 (1996) 96-105
7. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., and Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60 (1994) 436-444
8. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., and Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152 (1995) 1372-1376
9. Bissette G., Klimek V., Pan J., Stockmeier C., and Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28 (2003) 1328-1335
10. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., et al. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24 (2004) 1478-1485
11. Van Bockstaele E.J., Colago E.E., and Valentino R.J. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: Substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol 10 (1998) 743-757
12. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22 (2000) 148-162
13. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev 15 (1990) 71-100
14. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43 (1991) 425-473
15. McEwen B.S. Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain. Metabolism 54 (2005) 20-23
16. Heuser I., Yassouridis A., and Holsboer F. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatr Res 28 (1994) 341-356
17. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., and Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1085-1093
18. Watson S., Gallagher P., Smith M.S., Ferrier I.N., and Young A.H. The dex/CRH test-Is it better than the DST?. Psychoneuroendocrinology 31 (2006) 889-894
19. Kunugi H., Ida I., Owashi T., Kimura M., Inoue Y., Nakagawa S., et al. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: A Multicenter Study. Neuropsychopharmacology 31 (2006) 212-220
20. Van Den Eede F., Van den Bossche B., Hulstijn W., Sabbe B.G., Cosyns P., and Claes S.J. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder. J Affect Disord 93 (2006) 259-263
21. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., and Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. J Psychiatr Res 35 (2001) 83-94
22. Appelhof B.C., Huyser J., Verweij M., Brouwer J.P., van Dyck R., Fliers E., et al. Glucocorticoids and relapse of major depression. Biol Psychiatry 59 (2006) 696-701
23. Holsboer F., Lauer C.J., Schreiber W., and Krieg J.C. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62 (1995) 340-347
24. Modell S., Lauer C.J., Schreiber W., Huber J., Krieg J.C., and Holsboer F. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18 (1998) 253-262
25. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36 (2004) 1319-1325
26. Hammen C. Life events and depression: The plot thickens. Am J Community Psychol 20 (1992) 179-193
27. Agid O., Kohn Y., and Lerer B. Environmental stress and psychiatric illness. Biomed Pharmacother 54 (2000) 135-141
28. Hammen C., Henry R., and Daley S.E. Depression and sensitization to stressors among young women as a function of childhood adversity. J Consult Clin Psychol 68 (2000) 782-787
29. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 24 (2001) 1161-1192
30. Gorman J.M., Mathew S., and Coplan J. Neurobiology of early life stress: Nonhuman primate models. Semin Clin Neuropsychiatry 7 (2002) 96-103
31. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat Neurosci 7 (2004) 847-854
32. Heim C., Plotsky P.M., and Nemeroff C.B. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 29 (2004) 641-648
33. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
34. Bremner J.D., Vermetten E., and Mazure C.M. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: The Early Trauma Inventory. Depress Anxiety 12 (2000) 1-12
35. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV (1997), American Psychiatric Press, Washington, DC
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 12 (1960) 56
37. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8 (1995) 75-90
38. Sarason I.G., Johnson J.H., and Siegel J.M. Assessing the impact of life changes: Development of the Life Experiences Survey. J Consult Clin Psychol 46 (1978) 932-946
39. Resnick H.S., Kilpatrick D.G., Dansky B.S., Saunders B.E., and Best C.L. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol 61 (1993) 884-919
40. Linton E.A., and Lowry P.J. Corticotrophin releasing factor in man and its measurement: A review. Clin Endocrinol 31 (1989) 225-249
41. Pruessner J.C., Kirschbaum C., Meinlschmid G., and Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
42. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. (1988), Erlbaum, Hillsdale, New York
43. Erdfelder E., Faul S., and Buchner A. G-power: A general power analysis program. Behav Res Meth Instr Comp 28 (1996) 1-11
44. Heim C., Newport D.J., Heit S., Graham Y.P., Wilcox M., Bonsall R., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284 (2000) 592-597
45. Vythilingam M., Heim C., Newport J., Miller A.H., Anderson E., Bronen R., et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 159 (2002) 2072-2080
46. Rinne T., de Kloet E.R., Wouters L., Goekoop J.G., DeRijk R.H., and van den Brink W. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry 52 (2002) 1102-1112
47. Keck M.E., Wigger A., Welt T., Muller M.B., Gesing A., Reul J.M., et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: Implications for pathogenesis of affective disorders. Neuropsychopharmacology 26 (2002) 94-105
48. Kaufman J., Birmaher B., Perel J., Dahl R.E., Moreci P., Nelson B., et al. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Biol Psychiatry 42 (1997) 669-679
49. Barr C.S., Newman T.K., Schwandt M., Shannon C., Dvoskin R.L., Lindell S.G., et al. Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc Natl Acad Sci U S A 101 (2004) 12358-12363
50. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
51. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., and Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Arch Gen Psychiatry 62 (2005) 529-535
52. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 101 (2004) 17316 -1721
53. Yehuda R. Post-traumatic stress disorder. N Engl J Med 346 (2002) 108-114
54. Hardt J., and Rutter M. Validity of adult retrospective reports of adverse childhood experiences: Review of the evidence. J Child Psychol Psychiatry 45 (2004) 260 -173
55. Kudielka B.M., and Kirschbaum C. Sex differences in HPA axis responses to stress: A review. Biol Psychol 69 (2005) 113-132
56. Weiss E.L., Longhurst J.G., and Mazure C.M. Childhood sexual abuse as a risk factor for depression in women: Psychosocial and neurobiological correlates. Am J Psychiatry 156 (1999) 816-828